SANTIAGO
MUÑOZ FERNANDEZ
PROFESOR DOCTOR
Hospital General Universitario de Alicante
Alicante, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (13)
2021
-
Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey
Joint Bone Spine, Vol. 88, Núm. 4
2020
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2018
-
Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis
Reumatologia Clinica, Vol. 14, Núm. 6, pp. 320-333
-
Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence
Rheumatology International, Vol. 38, Núm. 12, pp. 2289-2296
2017
-
Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis
Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1200-1209
2014
-
PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis
Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769
2011
-
Documento SER de consenso sobre el uso de terapias biológicas en la espondilitis anquilosante y otras espondiloartritis, excepto la artritis psoriásica
Reumatologia Clinica, Vol. 7, Núm. 2, pp. 113-123